December 2, 2016 Conference
Focusing on Yesterday, Today and Tomorrow: Presbyopic IOLs, where are we?
Return to Session
Dr. Roberto Pineda II, MEEI (Presenter)
Speaker Session Topic
The first presbyopic IOL was introduced nearly two decades ago (AMO Array 1997). Both mechanical and multifocal IOL strategies have been applied to create an extended range of vision after cataract surgery. Refractive optics have been replaced by diffractive and apodized optics. Alternatively, accommodating IOLs have yielded only adequate results. Currently, a range of diffractive multifocal IOLs are available depending on lifestyle but with compromised visual quality. However, a recently FDA-approved extended depth of focus (EDOV) lens mitigates some side effects at the expense of near vision. Overseas, trifocal IOLs are available including the Zeiss’ AT LISA tri, PhysIOL’s FineVision and Alcon’s Arcysof IQ PanOptix. These IOLs have less intermediate vision dip while maintaining reading vision. Also, these IOLs have less halos/glare and rates of dysphotopsia similar to EDOV IOLs. Additionally, newer accommodative IOLs are coming which change focus by changing lens curvature or through dual optics such as the Power Vision’s in-the-bag FluidVision, NuLens’ sulcus-fixated DynaCurve and Akkolens Lumina. As presbyopic IOL technology progresses, outcomes will improve and side effects will decrease.